Mutant Drug-Resistant Ebola Created by U.S., China, U.K., Germany Just Before Africa Outbreak: Journal ‘npj Viruses’

The fact that countries portrayed as enemies are cooperating on such things is a fingerprint of the world being ran by the OCGFC, Owners and Controllers of Global Financialized Capital. And we had the US and China cooperating on the lab creation of COVID, which wasn’t really all that dangerous unless you had a compromised immune system or the white coats got you in the hospital to kill you with their treatment protocols, as paid for by the state. And they made billions poisoning people with untested gene therapies killing and creating more sick people to profit from with their pharmaceutical poisons. No matter what they want to do now, God puts limits on them until His church is extracted. But an interesting question, would the threat of a more lethal outbreak convince you to take their next gene therapy? Perhaps a clue for the timing is in Revelation 6:7-8, and notice the “they” are given authority to kill a fourth of the earth with “pestilence” being one such method.

Revelation 6:7–8

[7] When he opened the fourth seal, I heard the voice of the fourth living creature say, “Come!” [8] And I looked, and behold, a pale horse! And its rider’s name was Death, and Hades followed him. And they were given authority over a fourth of the earth, to kill with sword and with famine and with pestilence and by wild beasts of the earth. (ESV)

https://jonfleetwood.substack.com/p/mutant-drug-resistant-ebola-created

Gain-of-function experiments that mutate pathogens to resist drugs are baked into virological drug development.

By Jon Fleetwood

An international research consortium involving major institutions from the United States, China, the United Kingdom, and Germany claims to have successfully created mutant strains of Orthoebolavirus that are resistant to the neutralizing effects of the monoclonal antibody mAb 11886.

They published their work in npj Viruses on May 7, just days before the 2026 Ebola outbreak was first officially reported by the Democratic Republic of the Congo’s Ministry of Public Health.

These Ebola experiments, which were conducted under BSL-4 conditions at Philipps University Marburg, involved the intentional generation and selection of purported viral variants that bypass therapeutic neutralization.

The experiments align with published gain-of-function (GOF) definitions.

According to a 2022 review published in Advances in Applied Microbiology:

“Gain-of-Function research on viruses is enhancing transmissibility, virus replication, virulence, host range, immune evasion or drug and vaccine resistance to get insights into the viral mechanisms, to create and analyze animal models, to accelerate drug and vaccine development and to improve pandemic preparedness.”

The new Ebola study was said to have resulted in the generation of mutated, drug-resistant Ebola pathogens in the name of drug development.

It raises international security concerns, as Congress, the White House, the Department of Energy, the FBI, the CIA, and Germany’s Federal Intelligence Service (BND) all acknowledged that the COVID-19 pandemic was “likely” the result of a laboratory incident involving engineered pathogens.

You can contact NIAID here, NIH here, and HHS here to voice opposition to taxpayer-funded research on pandemic pathogens.

Multiple U.S. government Ebola preparedness and response programs were administratively updated on the federal Assistance Listings database in mid-January 2026—roughly three to four months before health authorities in the Democratic Republic of the Congo announced the latest Ebola outbreak.

The Trump administration is now seeking more than $1.4 billion in Ebola funding from Congress, just after the CDC activated $107 million in emergency funding for Ebola response.

U.S. taxpayers are now paying for both the creation of mutated, drug-resistant Ebola pathogens while also paying for the government’s expensive response to Ebola.